HK1166791A1 - Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2-(1h)pyridone compounds and salts thereof and their applications 1-()-5--2-(1h) - Google Patents
Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2-(1h)pyridone compounds and salts thereof and their applications 1-()-5--2-(1h)Info
- Publication number
- HK1166791A1 HK1166791A1 HK12107432.7A HK12107432A HK1166791A1 HK 1166791 A1 HK1166791 A1 HK 1166791A1 HK 12107432 A HK12107432 A HK 12107432A HK 1166791 A1 HK1166791 A1 HK 1166791A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- trifluoromethyl
- salts
- applications
- preparation
- substituted benzyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910043502 | 2009-05-25 | ||
PCT/CN2010/073131 WO2010135976A1 (zh) | 2009-05-25 | 2010-05-24 | 1-(取代苄基)-5-三氟甲基-2-(1h)吡啶酮化合物及其盐,其制备方法及其用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1166791A1 true HK1166791A1 (en) | 2012-11-09 |
Family
ID=43222161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12107432.7A HK1166791A1 (en) | 2009-05-25 | 2012-07-30 | Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2-(1h)pyridone compounds and salts thereof and their applications 1-()-5--2-(1h) |
Country Status (10)
Country | Link |
---|---|
US (1) | US8377932B2 (es) |
EP (1) | EP2474533B1 (es) |
JP (1) | JP5722883B2 (es) |
KR (1) | KR101478133B1 (es) |
CN (1) | CN102149683B (es) |
AU (1) | AU2010252451B2 (es) |
DK (1) | DK2474533T3 (es) |
ES (1) | ES2536200T3 (es) |
HK (1) | HK1166791A1 (es) |
WO (1) | WO2010135976A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2010012848A (es) | 2008-06-03 | 2011-03-01 | Intermune Inc | Compuestos y metodos para tratar trastornos inflamatorios y fibroticos. |
JP5924984B2 (ja) * | 2012-03-06 | 2016-05-25 | 国立大学法人東京農工大学 | トリフルオロメチルピリジノン化合物およびその製造方法 |
JP6186434B2 (ja) | 2012-07-18 | 2017-08-23 | サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. | 窒素複素環誘導体及びその医薬品への応用 |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
KR20150018127A (ko) * | 2013-08-09 | 2015-02-23 | 삼성전자주식회사 | 디스플레이 장치 및 그 방법 |
EP3083584B1 (en) | 2013-12-19 | 2018-02-21 | Sunshine Lake Pharma Co., Ltd. | Nitrogenous heterocyclic derivatives and their application in the treatment of tissue fibrosis |
CN106459042B (zh) | 2014-04-02 | 2019-06-28 | 英特穆恩公司 | 抗纤维化吡啶酮类 |
CN106466318B (zh) * | 2015-08-21 | 2019-01-01 | 中南大学 | 1-杂环取代苄基吡啶酮类化合物在制备治疗糖尿病肾病药物中的应用 |
CN107663167A (zh) * | 2016-10-19 | 2018-02-06 | 广州南新制药有限公司 | 1‑(取代苄基)‑5‑三氟甲基‑2(1h)‑吡啶酮盐酸盐的晶型及制备方法 |
CN107652228B (zh) * | 2016-10-28 | 2020-04-14 | 广州南新制药有限公司 | 抗肾纤维化药物1-(取代苄基)-5-三氟甲基-2(1h)-吡啶酮盐酸盐的合成方法 |
CN113456642B (zh) * | 2021-07-09 | 2022-09-06 | 中南大学 | 一种美氟尼酮在制备治疗急性肾损伤药物中的应用 |
WO2023168649A1 (zh) * | 2022-03-10 | 2023-09-14 | 广州南新制药有限公司 | 一种美氟尼酮盐酸盐的制备方法 |
WO2023168650A1 (zh) * | 2022-03-10 | 2023-09-14 | 广州南新制药有限公司 | 一种美氟尼酮晶型的制备方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3839346A (en) | 1972-12-18 | 1974-10-01 | Affiliated Med Res | N-substituted pyridone and general method for preparing pyridones |
US4042699A (en) | 1972-12-18 | 1977-08-16 | Affiliated Medical Research, Inc. | Method for reducing serum glucose levels |
US4052509A (en) | 1972-12-18 | 1977-10-04 | Affiliated Medical Research, Inc. | Method for reducing serum uric acid levels |
GB8523126D0 (en) * | 1985-09-19 | 1985-10-23 | Ici Plc | Aryl pyridones |
GB8621217D0 (en) | 1986-09-03 | 1986-10-08 | Ici Plc | Chemical compounds |
GB8825314D0 (en) | 1988-10-28 | 1988-11-30 | Ici Plc | Chemical compounds |
GB9006479D0 (en) | 1989-04-17 | 1990-05-23 | Ici Plc | Novel compounds |
US5310562A (en) | 1989-11-22 | 1994-05-10 | Margolin Solomon B | Composition and method for reparation and prevention of fibrotic lesions |
US5518729A (en) | 1989-11-22 | 1996-05-21 | Margolin; Solomon B. | Compositions and methods for reparation and prevention of fibrotic lesions |
US5716632A (en) | 1989-11-22 | 1998-02-10 | Margolin; Solomon B. | Compositions and methods for reparation and prevention of fibrotic lesions |
US5238906A (en) | 1990-11-27 | 1993-08-24 | Sumitomo Chemical Company, Limited | Pyridone derivatives and use |
DE4343528A1 (de) | 1993-12-16 | 1995-06-22 | Schering Ag | Zweifach heterocyclisch substituierte Benzole und Pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel |
ES2334990T3 (es) * | 2002-02-14 | 2010-03-18 | Pharmacia Corporation | Piridinonas sustituidas como moduladores de p38 map quinasa. |
CN1218942C (zh) * | 2002-06-11 | 2005-09-14 | 中南大学湘雅医学院 | 抗纤维化吡啶酮化合物及其生产工艺方法 |
US7166603B2 (en) | 2003-07-23 | 2007-01-23 | Bristol-Myers Squibb Co. | Dihydropyrimidone inhibitors of calcium channel function |
GB0324159D0 (en) * | 2003-10-15 | 2003-11-19 | Glaxo Group Ltd | Novel compounds |
JP4614884B2 (ja) * | 2003-11-14 | 2011-01-19 | シャンハイ ゲノミックス インク | ピリドンの誘導体とその使用 |
DE102004027359A1 (de) | 2004-06-04 | 2005-12-29 | Abbott Gmbh & Co. Kg | Pyridin-2-onverbindungen und deren Verwendung |
KR20080023680A (ko) * | 2005-05-10 | 2008-03-14 | 인터뮨, 인크. | 스트레스-활성화 단백질 키나제 시스템을 조절하기 위한피리돈 유도체 |
ZA200709593B (en) | 2005-05-10 | 2009-06-24 | Intermune Inc | Pyridone derivatives for modulating stress-activated protein kinase system |
WO2007053610A2 (en) | 2005-11-01 | 2007-05-10 | The Regents Of The University Of California | Methods of treating atrial fibrillation wtih pirfenidone |
KR20080076968A (ko) | 2005-11-23 | 2008-08-20 | 인터뮨, 인크. | 스트레스-활성화 단백질 키나제 시스템을 조절하는 방법 |
CN101235030A (zh) * | 2007-01-30 | 2008-08-06 | 中南大学 | 1-取代-5-三氟甲基-2-(1h)吡啶酮化合物、制备方法及其用途 |
US20090118135A1 (en) | 2007-06-08 | 2009-05-07 | The Burnham Institute | Methods and compounds for regulating apoptosis |
CN101371833A (zh) | 2007-08-23 | 2009-02-25 | 中南大学 | 1-芳基-2(1h)-吡啶酮类化合物在制备治疗皮肤瘙痒药物中的应用 |
MX2010012848A (es) | 2008-06-03 | 2011-03-01 | Intermune Inc | Compuestos y metodos para tratar trastornos inflamatorios y fibroticos. |
AU2010206543A1 (en) | 2009-01-26 | 2011-07-07 | Intermune, Inc. | Methods for treating acute myocardial infarctions and associated disorders |
WO2010135470A1 (en) | 2009-05-19 | 2010-11-25 | Intermune, Inc. | Pifenidone derivatives for treating bronchial asthma |
-
2010
- 2010-05-24 ES ES10780057.5T patent/ES2536200T3/es active Active
- 2010-05-24 DK DK10780057.5T patent/DK2474533T3/en active
- 2010-05-24 CN CN2010800025776A patent/CN102149683B/zh active Active
- 2010-05-24 EP EP10780057.5A patent/EP2474533B1/en not_active Not-in-force
- 2010-05-24 JP JP2012512189A patent/JP5722883B2/ja not_active Expired - Fee Related
- 2010-05-24 KR KR1020117030958A patent/KR101478133B1/ko active IP Right Grant
- 2010-05-24 AU AU2010252451A patent/AU2010252451B2/en not_active Ceased
- 2010-05-24 US US13/322,153 patent/US8377932B2/en active Active
- 2010-05-24 WO PCT/CN2010/073131 patent/WO2010135976A1/zh active Application Filing
-
2012
- 2012-07-30 HK HK12107432.7A patent/HK1166791A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20120129859A1 (en) | 2012-05-24 |
WO2010135976A1 (zh) | 2010-12-02 |
US8377932B2 (en) | 2013-02-19 |
CN102149683A (zh) | 2011-08-10 |
AU2010252451B2 (en) | 2014-04-03 |
EP2474533A4 (en) | 2012-11-14 |
EP2474533A1 (en) | 2012-07-11 |
JP2012527488A (ja) | 2012-11-08 |
DK2474533T3 (en) | 2015-05-18 |
AU2010252451A1 (en) | 2011-12-15 |
EP2474533B1 (en) | 2015-02-25 |
JP5722883B2 (ja) | 2015-05-27 |
KR101478133B1 (ko) | 2014-12-31 |
ES2536200T3 (es) | 2015-05-21 |
CN102149683B (zh) | 2013-10-02 |
KR20120060785A (ko) | 2012-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1166791A1 (en) | Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2-(1h)pyridone compounds and salts thereof and their applications 1-()-5--2-(1h) | |
HK1243417A1 (zh) | 吡啶酮和氮雜吡啶酮化合物及使用方法 | |
HK1164297A1 (en) | Preparation of 1-(substituted aryl)-5-trifluoromethyl-2-(1h)-pyridone compounds and salts thereof and their applications 1-()-5--2-(1h) | |
IL246600B (en) | Heterocyclic compounds and their use | |
TWI561512B (en) | Novel nicotinamide derivative or salt thereof | |
IL209196A (en) | A crystalline form of posaconazole | |
IL222288A0 (en) | Heterocyclic compounds and their uses | |
EP2637669A4 (en) | Heterocyclic compounds and their use | |
ZA201301120B (en) | Heterocyclic compound and use thereof | |
IL220237A0 (en) | Divalent and oxabridged heterocyclic nicotine related compounds and preparation methods thereof | |
EP2575462A4 (en) | Heterocyclic compounds and their use | |
EP2640190A4 (en) | MODIFIED NICOTINIC COMPOUNDS AND ASSOCIATED METHODS | |
EP2604597A4 (en) | HETEROCYCLIC COMPOUND AND USE THEREOF | |
EP2548859A4 (en) | PREPARATION OF METHYL-D3-AMINE AND SALTS THEREOF | |
SI2635563T1 (sl) | Kristaliniäśne oblike hidrokloridne soli (4a-r,9a-s)-1-(1h-benzoimidazol -5-karbonil)-2,3,4,4a,9,9a-heksahidro-1h-indeno(2,1-b)piridin-6- karbonitrila in njihove uporabe kot inhibitorji hsd | |
IL223721A0 (en) | Heterocyclic compounds, their preparation and their therapeutic application | |
EP2265586A4 (en) | PREPARATION OF MONTELUKAST AND ITS SALTS | |
BRPI1012666A2 (pt) | cocristal de etravirina e nicotinamida | |
HK1185513A1 (en) | Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof 4-() | |
EP2597095A4 (en) | FUSED HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | |
PL2582240T3 (pl) | Chwastobójcza kompozycja soli kwasu pikolinowego | |
ZA201207945B (en) | Salts of dexlansoprazole and their preparation | |
ZA201303872B (en) | Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines | |
GB2478317B (en) | Herbicidal composition and method of use thereof | |
EP2582690A4 (en) | PROCESS FOR THE PREPARATION OF 2,3-DIARYL-5-SUBSTITUTED PYRIDINES AND INTERMEDIATES THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220520 |